Large vaccine trials that are extensive both in size and scope tax the resources of sponsors and contract research organizations (CROs), particularly when the trials seek to compress a process that ordinarily takes years. Rapid but safe implementation of these vaccine studies’ new protocols is pushing trial design to the limit.
Virtual meetings are now an essential part of doing business for life science organizations. But your approach to virtual engagement and online collaboration will vary based on the phase of the pharmaceutical lifecycle development, participant type, and internal teams involved.
What if we could look inside the minds of HCPs to see what is happening there during industry events and interactions?
This is a case study by TechEmergence, an artificial intelligence market research and media platform.
